The Infinite Brief

The layoffs include the operations teams, which were focused on the company’s growth and scaling efforts.

In the coming months, the company plans to tighten its focus on the direct-to-consumer business and its therapeutics arm while scaling back its clinical studies arm.

CEO Anne Wojcicki noted that privacy could be a factor, acknowledging that “privacy is top of mind” both for consumers and her executive team.